Guangdong Lifestrong Pharmacy Co., Ltd.

Equities

301111

CNE1000054T7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-21 pm EDT 5-day change 1st Jan Change
16.5 CNY +0.73% Intraday chart for Guangdong Lifestrong Pharmacy Co., Ltd. -2.25% -32.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangdong Lifestrong Pharmacy Approves Final Cash Dividend on A Shares for 2022, Effective 01 June 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022. CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 3-DEC-2022. CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangdong Lifestrong Pharmacy to Free Up Nearly 2 Million Shares For Trading MT
Guangdong Lifestrong Pharmacy Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 26, 2022 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Approves Cash Dividend for 2021 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Proposes Cash Dividend for 2021 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Guangdong Lifestrong Pharmacy Co., Ltd. has withdrawn its IPO. CI
Guangdong Lifestrong Pharmacy Co., Ltd. has filed an IPO. CI
Chart Guangdong Lifestrong Pharmacy Co., Ltd.
More charts
Guangdong Lifestrong Pharmacy Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Chinese patent medicines. The Company is also engaged in the production and sales of masks. The Company's main products include XiaoyanLidan Tablets, Danshitong Capsules, CanqiJiangtang Tablets, Kumu Injection, Fuyanping Capsules, Guipi Liquid, Gujing Bushen Pills, Jianer Qingjie Liquid and other medicines. The Company's products application scope covers biliary tract, hypoglycemic, heat clearing and detoxification, gynecology, tonic, pediatrics, cough and asthma, cardio cerebrovascular, cold, urology, digestion, rheumatism and traumatology.
More about the company
  1. Stock Market
  2. Equities
  3. 301111 Stock
  4. News Guangdong Lifestrong Pharmacy Co., Ltd.
  5. Guangdong Lifestrong Pharmacy to Free Up Nearly 2 Million Shares For Trading